Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
TAYD, VFS, AYI, More
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
TAYD, VFS, AYI, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.16), versus ($0.21) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Cardinal Health extends CVS Health drug distribution deal through 2032
- H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
